Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally

scientific article

Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JMV.2102
P698PubMed publication ID11745943

P50authorDevra DavisQ5267942
Jonathan L. HeeneyQ39066258
P2093author name stringvan der Groen G
Kestens L
Janssens W
Heyndrickx L
Willems B
Ondoa P
Coppens S
van der Berg I
P2860cites workIsolation of simian immunodeficiency viruses from two sooty mangabeys in Côte d'Ivoire: virological and genetic characterization and relationship to other HIV type 2 and SIVsm/mac strainsQ39346434
Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Côte d'IvoireQ39346459
High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeysQ39592712
In Vivo Sequence Variation of the Human Immunodeficiency Virus Type 1envGene: Evidence for Recombination Among Variants Found in a Single IndividualQ43661193
Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infectionsQ44138263
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinantQ45018234
Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressorsQ45750292
The evolutionary rate of nonpathogenic simian immunodeficiency virus (SIVagm) is in agreement with a rapid and continuous replication in vivoQ45768259
Systematic identification of T-cell activating epitopes on the human immunodeficiency virus type 1 envelope glycoprotein gp120 in primates immunized with synthetic peptidesQ45786781
Quantitation of human immunodeficiency virus type 1 in the blood of infected personsQ45844274
V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patients.Q49126722
Autologous neutralizing antibodies to SIVsm in cynomolgus monkeys correlate to prognosis.Q54225799
Recombination in HIV-1Q57998149
Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infectionQ77386243
Recombination in AIDS virusesQ22252829
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceQ24286950
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infectionQ28304764
Sequence analysis of a highly divergent HIV-1-related lentivirus isolated from a wild captured chimpanzeeQ30423988
Immune and hematopoietic parameters in HIV-1-infected chimpanzees during clinical progression toward AIDS.Q33500138
A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progressionQ33604871
Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytesQ33805324
Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virusQ33812785
Genetic organization of a chimpanzee lentivirus related to HIV-1.Q34028341
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope proteinQ34301897
Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41Q36230737
Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patientQ37031589
Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infectionQ38575178
Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assayQ38900270
Virologic and serologic characteristics of a natural chimpanzee lentivirus infectionQ39346423
P433issue4
P921main subjectchimpanzeeQ4126704
P304page(s)765-776
P577publication date2001-12-01
P1433published inJournal of Medical VirologyQ15716684
P1476titleGenetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally
P478volume65

Reverse relations

cites work (P2860)
Q33393641Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms
Q54220425Characterization of twin-cysteine motif in the V2-loop region of gp120 in primate lentiviruses.
Q31034710Evolution of the uniquely adaptable lentiviral envelope in a natural reservoir host
Q30332744Genetic recombination and its role in the development of the HIV-1 pandemic
Q36246353Noninvasive follow-up of simian immunodeficiency virus infection in wild-living nonhabituated western lowland gorillas in Cameroon
Q36667567Single real-time reverse transcription-PCR assay for detection and quantification of genetically diverse HIV-1, SIVcpz, and SIVgor strains
Q58395217The Evolution of Resistance to Simian Immunodeficiency Virus (SIV): A Review
Q34717558Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzees

Search more.